Respiratory News and Research

RSS

New information on pathogenesis of feeding and swallowing difficulties in kids with autism

Collaborative research out of the George Washington University (GW) reveals new information on the pathogenesis of feeding and swallowing difficulties often found in children with neurodevelopmental disorders, including autism and intellectual disability.

20 Feb 2014

Nintedanib plus docetaxel shows second-line efficacy in recurrent NSCLC

Nintedanib plus docetaxel offers significant efficacy in patients with non-small-cell lung cancer who experience disease progression after first-line chemotherapy, phase III study results show.

19 Feb 2014

Winnie Palmer Hospital for Women & Babies opens neonatal intensive care unit

Winnie Palmer Hospital for Women & Babies is opening the doors to an expansion of its neonatal intensive care unit (NICU). The expansion, which adds 30 beds to the hospital's existing 112-bed NICU, will make it the largest NICU in the world under one roof.

19 Feb 2014

Antibiotics prescribed for children who have URIs does not prevent complications

Antibiotics are often prescribed for young children who have upper respiratory tract infections (URIs) in order to prevent complications, such as ear infections and pneumonia, however, a new evidence review in The Cochrane Library found no evidence to support this practice.

19 Feb 2014

Taste receptors act as first line sentinels against infection in upper airway

The body uses mucus as a protective barrier to defend against pathogens, toxins, and allergens in the upper respiratory tract that can lead to such conditions as chronic sinusitis.

19 Feb 2014

COPD sufferers can reduce risk of being hospitalized by walking 3 kilometers a day

New research in Respirology shows that suffers of Chronic obstructive pulmonary disease (COPD) can reduce their risk of being hospitalized with severe attacks, by maintaining an exercise regime of walking between three to six kilometers a day.

19 Feb 2014

BioFire Diagnostics submits FilmArray GI Panel to FDA for 510(k) clearance

BioFire Diagnostics, LLC today announced that it has submitted the FilmArray Gastrointestinal (GI) Panel to the U.S. Food and Drug Administration for 510(k) clearance. The comprehensive FilmArray GI Panel tests for over 20 common bacteria, viruses and parasites that cause infectious diarrhea.

18 Feb 2014

Bioline enters Epigenetics field with launch of new EPIK product range

Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., announces that it has entered the rapidly growing Epigenetics field, with the launch of the first kits in the new EPIK™ product range; EPIK™ Fast Quantification Kit and EPIK™ Amplification Kit.

18 Feb 2014

Upstream interventions may provide options to contain emerging pathogens at source

While many endemic infectious diseases of humans have been largely contained, new microbes continue to emerge to threaten human and animal health.

18 Feb 2014

Children exposed to cigarette smoke may have lesser response to asthma treatment

Children exposed to cigarette smoke at home have lower levels of an enzyme that helps them respond to asthma treatment, a study has found.

17 Feb 2014

Doctors miss opportunities to diagnose COPD at an earlier stage in primary and secondary care

A retrospective study of almost 39,000 patients shows that opportunities to diagnose chronic obstructive pulmonary disease (COPD) at an earlier stage are frequently being missed in both primary and secondary care in the UK. The findings, published in The Lancet Respiratory Medicine, reveal missed opportunities to diagnose COPD occurred in up to 85% of people.

17 Feb 2014

Forest Laboratories plans to discontinue sale of NAMENDA 5 mg and 10 mg tablets

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, today announced that it plans to discontinue the sale of NAMENDA (memantine HCl) 5 mg and 10 mg tablets effective August 15, 2014.

16 Feb 2014

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

16 Feb 2014

Teleflex announces launch of Rusch DispoLED Single-Use Fiber Optic Laryngoscope Handle

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the launch of the Rusch® DispoLED™ Single-Use Fiber Optic Laryngoscope Handle — a cost-neutral way to combat cross-contamination infection risk during intubation.

14 Feb 2014

Researcher seeks best way to obtain parental consent for research regarding newborn resuscitation

For years, obtaining parental consent for clinical research regarding newborn resuscitation in the delivery room has been a challenge. Now, a Saint Louis University pediatric researcher is asking new mothers and pregnant women when doctors should seek parental permission to allow medical research related to delivery room treatments.

14 Feb 2014

Prothelia, University of Nevada, Reno and Alexion partner to develop Laminin-111 for MDC1A

Prothelia Incorporated and University of Nevada, Reno announce that they have entered into strategic agreements with Alexion for the development of Laminin-111, a patented experimental protein replacement therapy for merosin-deficient congenital muscular dystrophy (MDC1A), a life-threatening, ultra-rare disease caused by a genetic deficiency of the Laminin-211 protein.

13 Feb 2014

FDA grants full approval of SYNRIBO for injection

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has granted full approval of SYNRIBO (omacetaxine mepesuccinate) for injection. This oncology portfolio product received an accelerated approval in October, 2012 with additional clinical trial data required to fulfill post marketing requirements set forth by the FDA.

13 Feb 2014

Alvogen launches Inflectra into Central and Eastern Europe

Alvogen, the multinational pharmaceuticals company, today announced the launch of Inflectra (Infliximab) into Central and Eastern Europe. Inflectra, Europe's first biosimilar monoclonal antibody (mAb) therapy that has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.

13 Feb 2014

International study examines link between infections and ischemic stroke in children

Common infections are associated with a significantly higher chance of stroke in children, but routine vaccinations may help decrease risk, according to preliminary research (abstract 39) presented at the American Stroke Association's International Stroke Conference 2014.

12 Feb 2014

Microbiologists find way to use statins to fight Hantavirus

wo Perelman School of Medicine microbiologists may have found a way to use statins, the well-known blockbuster cholesterol-lowering drugs, to fight the hantavirus, a mysterious and lethal microorganism that appeared suddenly in the US southwest over 20 years ago.

12 Feb 2014

Respiratory News and Research

New information on pathogenesis of feeding and swallowing difficulties in kids with autism

Nintedanib plus docetaxel shows second-line efficacy in recurrent NSCLC

Winnie Palmer Hospital for Women & Babies opens neonatal intensive care unit

Antibiotics prescribed for children who have URIs does not prevent complications

Taste receptors act as first line sentinels against infection in upper airway

COPD sufferers can reduce risk of being hospitalized by walking 3 kilometers a day

BioFire Diagnostics submits FilmArray GI Panel to FDA for 510(k) clearance

Bioline enters Epigenetics field with launch of new EPIK product range

Upstream interventions may provide options to contain emerging pathogens at source

Children exposed to cigarette smoke may have lesser response to asthma treatment

Doctors miss opportunities to diagnose COPD at an earlier stage in primary and secondary care

Forest Laboratories plans to discontinue sale of NAMENDA 5 mg and 10 mg tablets

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

Teleflex announces launch of Rusch DispoLED Single-Use Fiber Optic Laryngoscope Handle

Researcher seeks best way to obtain parental consent for research regarding newborn resuscitation

Prothelia, University of Nevada, Reno and Alexion partner to develop Laminin-111 for MDC1A

FDA grants full approval of SYNRIBO for injection

Alvogen launches Inflectra into Central and Eastern Europe

International study examines link between infections and ischemic stroke in children

Microbiologists find way to use statins to fight Hantavirus

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News